Fudan University
Fudan University
Explore linked clinical trials.653 results · Page 1 of 27
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Family Physician Nudges for Influenza Vaccination Among Older Adults | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Not yet recruiting | Not applicable | 2026-10-08 | NCT07864597 | |
| Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid Dynamics | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Not stated | 2026-10-06 | NCT07860138 | |
| Vaccine Knowledge, Attitudes and Practices Among Men Who Have Sex With Men: a Global Cross-sectional Study | Vaccination | Not yet recruiting | Not stated | 2026-10-02 | NCT07856563 | |
| SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Early Breast Cancer After Pathologic Complete Response | Disease Attributes, Disease Progression, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 2 | 2026-10-02 | NCT07856303 | |
| Artificial Intelligence-assisted Primary Care for RSV Prevention (AIPC-RSV) in China | RSV Immunization | Not yet recruiting | Not applicable | 2026-10-02 | NCT07856290 | |
| Cryoablation Combined With Anlotinib Plus TQB2868 in Patients With Advanced Intrahepatic Cholangiocarcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, intrahepatic cholangiocarcinoma, neoplasm | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07846267 | |
| Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-09-29 | NCT06637150 | |
| Collective Motivational Interviewing (CMI) for Adolescents With Internet Gaming Disorder | Internet Gaming Disorder | Recruiting | Not applicable | 2026-09-29 | NCT05917977 | |
| CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-09-28 | NCT07432178 | |
| T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis | Breast Cancer With Brain Metastasis; HER2-positive Breast Cancer | Recruiting | Phase 2 | 2026-09-28 | NCT07152782 | |
| Capecitabine in Low Risk Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-09-28 | NCT06787339 | |
| TCb vs EC-T in High Risk ER+/HER2- Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Recruiting | Phase 3 | 2026-09-28 | NCT05901428 | |
| Exploring the Impact of Diurnal Variation on Coagulation Function in Patients Undering Tumor Surgery | Diurnal Variation of Coagulation Function | Enrolling by invitation | Not stated | 2026-09-25 | NCT07841613 | |
| ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm | Recruiting | Phase 2 | 2026-09-25 | NCT07841236 | |
| 1-Week Versus 3-Week PBI | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-09-25 | NCT07832279 | |
| Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 2 | 2026-09-25 | NCT07419880 | |
| T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis | Breast Cancer With Brain Metastasis; HER2-low Expressing Breast Cancer | Recruiting | Phase 2 | 2026-09-25 | NCT07150208 | |
| Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer | Advanced Breast Cancer; HR+/HER2- Breast Cancer | Active, not recruiting | Phase 3 | 2026-09-25 | NCT06447623 | |
| SCRT Combined With CAPOX and PD-1/CTLA4 Antibody for Early-stage Low Rectal Cancer | Early Low Rectal Cancer | Not yet recruiting | Phase 2 | 2026-09-23 | NCT07837362 | |
| Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic Therapy | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-09-23 | NCT07829848 | |
| Cola Ingestion for Esophageal Bolus Impaction | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasm | Active, not recruiting | Not applicable | 2026-09-23 | NCT06652620 | |
| Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based Reconstruction | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-09-22 | NCT07835139 | |
| Cryoablation Combined With QL1706 (Iparomlimab/Tuvonralimab) Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer. | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm | Not yet recruiting | Phase 2 | 2026-09-21 | NCT07829874 | |
| Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Phase 3 | 2026-09-21 | NCT07132463 | |
| Neoadjuvant Immunochemotherapy for LAOSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Oral Squamous Cell Carcinoma, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 3 | 2026-09-21 | NCT06258811 |